Dry Eye News and Research

RSS
Dry eye is one of the most common complaints seen by eye doctors, accounting for nearly one fourth of all office visits. Caused by insufficient tear production or excessive tear evaporation, dry eye can be a mild, episodic feeling of discomfort associated with certain circumstances, such as exposure to dry, hot or windy environments; however, it can also be a chronic medical condition that, if left untreated, may lead to increased risk of infection or visual impairment.
Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

Rigel reports net loss of $25.6 million in first quarter 2013

Rigel reports net loss of $25.6 million in first quarter 2013

IL-1 antagonist relieves dry eyes

IL-1 antagonist relieves dry eyes

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Acucela begins phase 2b/3 clinical trial of emixustat hydrochloride to treat GA associated with dry AMD

Arthritis drug reduces dry eye disease

Arthritis drug reduces dry eye disease

Research findings provide new hope for people suffering from dry eye disease

Research findings provide new hope for people suffering from dry eye disease

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

Tips to help reduce dry eyes

Tips to help reduce dry eyes

Data from Eleven Biotherapeutics' EBI-005 preclinical study on ocular diseases

Data from Eleven Biotherapeutics' EBI-005 preclinical study on ocular diseases

Watch out for Sjögren's syndrome in dry eye

Watch out for Sjögren's syndrome in dry eye

Esthesiometry may help vision professionals in evaluating dry eyes

Esthesiometry may help vision professionals in evaluating dry eyes

Enrollment complete in DOUBle Phase 3 clinical trial of AzaSite Plus and DexaSite for blepharitis

Enrollment complete in DOUBle Phase 3 clinical trial of AzaSite Plus and DexaSite for blepharitis

DuraSite 2 ophthalmic drug delivery system from InSite Vision

DuraSite 2 ophthalmic drug delivery system from InSite Vision

New treatment for severe dry eye is now available at U-M’s Kellogg

New treatment for severe dry eye is now available at U-M’s Kellogg

InSite Vision second quarter total revenues decrease to $1.8 million

InSite Vision second quarter total revenues decrease to $1.8 million

InSite Vision commences enrollment in BromSite Phase 3 clinical trial

InSite Vision commences enrollment in BromSite Phase 3 clinical trial

Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome

Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome

Jade, BioTime sign exclusive sublicense and supply agreement for HyStem

Jade, BioTime sign exclusive sublicense and supply agreement for HyStem

FDA grants Fast Track designation to Edimer’s EDI200 for treatment of XLHED

FDA grants Fast Track designation to Edimer’s EDI200 for treatment of XLHED